Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.'s share was trading at $29.76 as of April 21st. HIMS’s trailing and forward P/E were 60.80 and 72.99 respectively according to Yahoo Finance.
Hims & Hers Health, Inc. (Hims) is positioned as a vertically integrated digital healthcare platform transitioning from reactive treatment to preventive, data-driven medicine. The Q4 FY2025 update highlights...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.